
SHC
Sotera
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 0
Sell signal 3
Net Income Plunges
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SHC
Sotera Health Company
A leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry
Life Science Tools and Services
Invalid Date
11/20/2020
NASDAQ Stock Exchange
3,000
12-31
Common stock
9100 South Hills Blvd, Suite 300, Broadview Heights, Ohio 44147
--
Sotera Health Company was incorporated in Delaware in November 2017. The company is a leading global provider of critical sterilization and laboratory testing and consulting services for the medical device and pharmaceutical industries. The company provides end-to-end sterilization and microbiological and analytical laboratory testing and consulting services to help ensure that medical, pharmaceutical and food products are safe for medical practitioners, patients and consumers in the United States and around the world.
Earnings Call
Company Financials
EPS
SHC has released its 2025 Q1 earnings. EPS was reported at 0.14, versus the expected 0.12, beating expectations. The chart below visualizes how SHC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SHC has released its 2025 Q1 earnings report, with revenue of 254.52M, reflecting a YoY change of 2.56%, and net profit of -13.26M, showing a YoY change of -309.71%. The Sankey diagram below clearly presents SHC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available